How long does it take to see the therapeutic effect of Sotorasib?

Sotorasib is a targeted drug mainly used to treat non-small cell lung cancer (NSCLC) with KRAS G12C mutations. It helps reduce the proliferation and growth of cancer cells by specifically inhibiting the activity of KRAS G12C mutant protein. The effects of treatment vary from person to person, so the reaction time after taking the medication will also vary.

Generally speaking, it usually takes several weeks to several months for the therapeutic effects of sotoraxib to appear. Based on clinical studies and patient feedback, many patients can see signs of tumor shrinkage approximately 6 to 8 weeks after starting treatment, especially on imaging tests such as CT scans. Some patients may experience relief from symptoms in the first few weeks of treatment, such as improvement in coughing and dyspnea.

However, not all patients will see significant treatment effects in the short term. Some patients may take longer, even more than three months, to see significant tumor shrinkage or symptom relief. In addition, the effect of treatment is closely related to the patient's specific condition, the progression of the disease, and whether it is combined with other treatment options.

During the treatment process, doctors will conduct regular evaluations and monitor the efficacy and possible side effects of the drug through imaging examinations, blood indicators and other means. Patients should maintain close communication with their doctors to ensure timely adjustments to the treatment plan in order to achieve the best treatment effect. If you do not see the expected results during treatment, you may need to consider adjusting the treatment plan or adding other adjuvant treatments.

Reference materials:https://www.lumakras.com/